Dong-E-E-Jiao Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of donkey-hide gelatin and related products...
DEEJ has continuously received a Wind ESG A rating, with a comprehensive score of 7.73
AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement
China Resources Pharma's subsidiary DEEJ earned 1.739 billion RMB last year, an increase of 11.7%
DEEJ released its performance for the first three quarters, with a net profit attributable to the parent company of 1.274 billion yuan, a year-on-year increase of 10.53%
China Resources Pharmaceutical: DEEJ's net profit for the first three quarters is 1.277 billion yuan, an increase of 10.77% year-on-year
Guojin Securities: Terminal demand is gradually recovering, and the prosperity of the pharmaceutical and health industry is expected to rise